share_log

Universe Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

SEC ·  Sep 28, 2022 20:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more